Wave Life Sciences: Speculative, But Promising [Seeking Alpha]
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: Seeking Alpha
WVE-N531 for Duchenne muscular dystrophy shows potential best-in-class data and is on track for a likely 2027 approval, supporting the investment case. The company's diversified RNA platform and partnerships provide multiple shots on goal, but past clinical failures and no approvals to date warrant some caution. An analysis around Wave Life Sciences follows in the paragraphs below. Looking for more investing ideas like this one? Get them exclusively at The Biotech Forum. Learn More » Sergey Shulgin/iStock via Getty Images Shares of RNA medicines concern Wave Life Sciences Ltd. ( NASDAQ: WVE are down around 60% since November 2024, after posting solid data on its DMD exon 51 skipping candidate WVE-N531. Although that news potentially opens up a $2.4 billion Live Chat on The Biotech Forum has been dominated by discussion of covered call opportunities in recent quarters. To see what I and the other season biotech investors are targeting as trading ideas real-time, just initi
Show less
Read more
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) was given a new $32.00 price target on by analysts at UBS Group AG.MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..MarketBeat
- WAVE Life Sciences (NASDAQ:WVE) was given a new $50.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial [Yahoo! Finance]Yahoo! Finance
WVE
Earnings
- 11/10/25 - Miss
WVE
Sec Filings
- 12/15/25 - Form SCHEDULE
- 12/15/25 - Form 4
- 12/11/25 - Form 424B5
- WVE's page on the SEC website